GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hefei Hengxin Life Science and Technology Co 301501.SZ · CNY

Materials · Shenzhen · 🇨🇳 China

Compare

23.64

-0.96%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.84bn

FY2021FY2025

Net income

CN¥223.8m

FY2021FY2025

Free cash flow

−CN¥188.4m

FY2021FY2025

Shareholders' equity

CN¥2.11bn

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
RevenueCN¥1.84bnCN¥1.59bnCN¥1.43bnCN¥1.09bnCN¥718.9m
Research and developmentCN¥52.8mCN¥53.4mCN¥44.2mCN¥35.9mCN¥32.2m
Operating incomeCN¥293.4mCN¥266.1mCN¥269.9mCN¥195.6mCN¥95.8m
Net incomeCN¥223.8mCN¥219.9mCN¥213.9mCN¥162.8mCN¥80.3m
Diluted earnings per share1.511.981.451.100.54

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assetsCN¥2.85bnCN¥1.98bnCN¥1.57bnCN¥1.21bnCN¥727.9m
Total liabilitiesCN¥677.7mCN¥869.4mCN¥690.5mCN¥565.7mCN¥246.1m
DebtCN¥67.5mCN¥94.1mCN¥110.5mCN¥74.4m—
Shareholders' equityCN¥2.11bnCN¥1.05bnCN¥821.5mCN¥608.8m—
Shares outstanding148m111m148m148m148m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operationsCN¥339.6mCN¥373.8mCN¥219.5mCN¥292.6mCN¥143.9m
Capital spending−CN¥528.0m−CN¥452.6m−CN¥330.3m−CN¥290.1m−CN¥134.1m
Free cash flow−CN¥188.4m−CN¥78.7m−CN¥110.9mCN¥2.6mCN¥9.8m
Dividends paid−CN¥58.8m−CN¥11.4m−CN¥7.6m−CN¥19.5m−CN¥9.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
RevenueCN¥484.9mCN¥450.5mCN¥460.7mCN¥451.8mCN¥419.1mCN¥435.7mCN¥455.4mCN¥395.5m
Operating incomeCN¥38.4mCN¥41.8mCN¥57.0mCN¥63.1mCN¥58.3m−CN¥892.3mCN¥455.4mCN¥69.9m
Net incomeCN¥29.8mCN¥32.3mCN¥39.0mCN¥43.5mCN¥81.9mCN¥57.9mCN¥60.7mCN¥59.2m
Diluted earnings per share0.200.220.260.290.550.520.550.53
Capital spending−CN¥147.0m−CN¥98.0m−CN¥123.0m−CN¥113.0m−CN¥98.0m——−CN¥81.0m
Total assetsCN¥2.81bnCN¥2.80bnCN¥2.85bnCN¥2.73bnCN¥2.90bnCN¥1.98bnCN¥1.86bnCN¥1.74bn
DebtCN¥102.5mCN¥72.5mCN¥67.5mCN¥72.5mCN¥94.1mCN¥94.1m—CN¥110.8m
Shareholders' equityCN¥2.09bnCN¥2.12bnCN¥2.11bnCN¥2.00bnCN¥2.03bnCN¥1.05bnCN¥993.1mCN¥926.5m

Financial ratios

Data as of 12 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Operating margin16.1%17.6%18.9%18.4%100.0%
Net margin12.1%13.8%15.0%15.0%11.2%
Return on equity10.6%21.0%26.0%26.7%—
Return on assets7.8%11.1%13.6%13.4%11.0%
Free cash flow yield21.5%27.4%———
Revenue growth15.7%11.9%30.9%51.4%—
Earnings growth1.8%2.8%31.4%102.8%—
Current ratio2.12x1.03x1.32x1.40x1.88x
Debt to equity0.03x0.09x0.13x0.12x—
Equity ratio73.8%52.7%52.2%50.2%—
Interest coverage39.86x14.01x25.29x22.77x274.65x
R&D as a share of sales2.9%3.3%3.1%3.3%4.5%
Buybacks as a share of market value-33.3%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.4%——
Operating income14.5%——
Net income11.2%——

Valuation history

At each fiscal year end

FY2025
Price to earnings28.9
Price to sales3.5

Dividends and splits

Per share, in the currency the company pays

Paid for 1 years. Last went ex-dividend on 6 Jun 2025.

FY2025
Paid in the year0.345

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.